Advancements in Prime Editing Bring Hope for Genetic Disease Treatment
Prime editing holds the promise of correcting a vast array of harmful genetic mutations responsible for many diseases. However, despite its potential, this innovative technique, introduced in 2019, has yet to make significant inroads in direct applications within the body, known as in vivo treatments. Currently, the sole publicly disclosed clinical application involves editing cells externally before they are reintroduced into the patient.
Comments